Ask AI
ProCE Banner Activity

Emerging DLL3-Targeted Therapies for Extrapulmonary Neuroendocrine Carcinomas

Slideset

Download these slides to learn about the current treatment landscape for poorly differentiated extrapulmonary neuroendocrine carcinomas and the role of emerging DLL3-targeted therapies for improving patient outcomes.

Released: September 30, 2025

Continue Activity

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc.